Tag: Vesicare

In clinical trials for overactive bladder, up to 13.4% of patients on the 10mg dose of solifenacin reported constipation, a significant increase over the placebo group. Yes, can solifenacin cause constipation, and understanding this potential side effect is crucial for patients.

Initially recognized for its role in managing symptoms of overactive bladder (OAB), solifenacin has a notable application for pediatric patients with neurogenic detrusor overactivity (NDO). This anticholinergic medication, known by the brand name Vesicare, is prescribed to address bladder control issues arising from neurological conditions. Understanding the scope of what else is solifenacin used for provides a more complete picture of its therapeutic value in urology.

Based on clinical trial data, dry mouth is the most common side effect reported in patients taking solifenacin, affecting up to 28% of adults. This article details **what are the most common side effects of solifenacin**, including dose-dependent increases in adverse reactions.